信立泰：第六届监事会第十次会议决议公告

Core Viewpoint - The company, Shenzhen Xinlitai Pharmaceutical Co., Ltd., announced the approval of a special report regarding the use and storage of raised funds for the first half of 2025 by its sixth supervisory board's tenth meeting [2] Group 1 - The company held a supervisory board meeting to review and approve the special report on the use of raised funds [2] - The report pertains to the financial activities and management of funds raised by the company [2]